131 related articles for article (PubMed ID: 5527012)
1. Comparison of the antileukemic effect in mice of adriamycin (NSC-123127) with daunomycin (NSC-82151).
Sandberg JS; Howsden FL; DiMarco A; Goldin A
Cancer Chemother Rep; 1970 Feb; 54(1):1-7. PubMed ID: 5527012
[No Abstract] [Full Text] [Related]
2. Activity of adriamycin (NSC-123127) and daunomycin (NSC-82151) against mouse mammary carcinoma.
Di Marco A; Lenaz L; Casazza AM; Scarpinato BM
Cancer Chemother Rep; 1972 Apr; 56(2):153-61. PubMed ID: 5043223
[No Abstract] [Full Text] [Related]
3. Activity of anthracyclines against an adriamycin (NSC-123127)-resistant subline of P388 leukemia with special emphasis on cinerubin A (NSC-18334).
Johnson RK; Ovejera AA; Goldin A
Cancer Treat Rep; 1976 Jan; 60(1):99-102. PubMed ID: 826316
[No Abstract] [Full Text] [Related]
4. Enhancement of antitumor effectiveness of ICRF-159 (NSC-129943) against early L1210 leukemia by combination with cis-diamminedichloroplatinum (NSC-119875) or daunomycin (NSC-82151).
Woodman RJ
Cancer Chemother Rep 2; 1974 Mar; 4(1):45-52. PubMed ID: 4826499
[No Abstract] [Full Text] [Related]
5. A new antitumor antibiotic, carminomycin (NSC-180024).
Gause GF; Brazhnikova MG; Shorin VA
Cancer Chemother Rep; 1974; 58(2):255-6. PubMed ID: 4830498
[No Abstract] [Full Text] [Related]
6. Antitumor activity of some derivatives of daunorubicin at the amino and methyl ketone functions.
Yamamoto K; Acton EM; Henry DW
J Med Chem; 1972 Aug; 15(8):872-5. PubMed ID: 5044313
[No Abstract] [Full Text] [Related]
7. Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943).
Woodman RJ; Cysyk RL; Kline I; Gang M; Venditti JM
Cancer Chemother Rep; 1975; 59(4):689-95. PubMed ID: 1175163
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin.
Stefańska B; Dzieduszycka M; Bontemps-Gracz M; Borowski E; Martelli S
J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607
[TBL] [Abstract][Full Text] [Related]
9. Letter: DNA complexes of daunorubicin (NSC-8215) and adriamycin (NSC-123127).
Trouet A; de Duve C
Cancer Chemother Rep; 1975; 59(2 Pt 1):260. PubMed ID: 1149004
[No Abstract] [Full Text] [Related]
10. [Comparative experimental study of the antileukemia activity of carminomycin and rubomycin].
Khanykova OK; Vinogorova GF
Antibiotiki; 1977 Sep; 22(9):846-52. PubMed ID: 911158
[TBL] [Abstract][Full Text] [Related]
11. Some determinants of the therapeutic efficacy of actinomycin D (NSC-3053), adriamycin (NSC-123127), and daunorubicin (NSC-83142).
Schwartz HS
Cancer Chemother Rep; 1974; 58(1):55-62. PubMed ID: 4521481
[No Abstract] [Full Text] [Related]
12. [Possibility of utilizing lymphatic leukemia L1210 as a first screening model in the primary selection of new antitumor antibiotics].
Shorin VA; Bazhanov VS
Antibiotiki; 1974 Aug; 19(8):679-84. PubMed ID: 4455117
[No Abstract] [Full Text] [Related]
13. Concanavalin A as a carrier of daunomycin.
Kitao T; Hattori K
Nature; 1977 Jan; 265(5589):81-2. PubMed ID: 834249
[No Abstract] [Full Text] [Related]
14. DNA--anthracycline complexes. I. Toxicity in mice and chemotherapeutic activity against L1210 leukemia of daunorubicin--DNA and adriamycin--DNA.
Deprez-de Campeneere D; Trouet A
Eur J Cancer (1965); 1980 Aug; 16(8):981-6. PubMed ID: 7439227
[No Abstract] [Full Text] [Related]
15. Tetrahydropyranyl derivatives of daunomycin and adriamycin.
Umezawa H; Takahashi Y; Kinoshita M; Naganawa H; Masuda T; Ishizuka M; Tatsuta K; Takeuchi T
J Antibiot (Tokyo); 1979 Oct; 32(10):1082-4. PubMed ID: 528373
[No Abstract] [Full Text] [Related]
16. [New anthracycline antibiotics and derivatives].
Tatsuta K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
[TBL] [Abstract][Full Text] [Related]
17. Erythrocyte entrapment of daunomycin by amphotericin B without hemolysis.
Kitao T; Hattori K
Cancer Res; 1980 Apr; 40(4):1351-3. PubMed ID: 7357561
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antitumor activity of new anthracyclines.
Florent JC; Genot A; Monneret C
J Antibiot (Tokyo); 1989 Dec; 42(12):1823-30. PubMed ID: 2621164
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological and therapeutic efficacy of rubidazone in mice. Comparison with daunomycin and adriamycin.
Ohnuma T; Elias F; Holland JF; Henderson E
Eur J Cancer (1965); 1979 Mar; 15(3):363-71. PubMed ID: 446517
[No Abstract] [Full Text] [Related]
20. Daunomycin pharmacological activity at the cellular level.
Di Marco A
Pathol Biol; 1967 Oct; 15(19):897-902. PubMed ID: 4297686
[No Abstract] [Full Text] [Related]
[Next] [New Search]
